2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
from NDTV Profit - Latest https://ift.tt/38rpZdn
from NDTV Profit - Latest https://ift.tt/38rpZdn
Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug
![Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug]()
Reviewed by placements page
on
August 31, 2021
Rating:
No comments: